Login / Signup
Lilla Bagameri
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 6
Top Topics
Current Status
Squamous Cell
Cardiovascular Disease
Silver Nanoparticles
Top Venues
Molecules (Basel, Switzerland)
Life (Basel, Switzerland)
Pharmaceutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Sara Botezan
,
Gabriela-Maria Baci
,
Lilla Bagameri
,
Claudia Paşca
,
Daniel Severus Dezmirean
Current Status of the Bioactive Properties of Royal Jelly: A Comprehensive Review with a Focus on Its Anticancer, Anti-Inflammatory, and Antioxidant Effects.
Molecules (Basel, Switzerland)
28 (3) (2023)
Lilla Bagameri
,
Sara Botezan
,
Otilia Bobiș
,
Victorita Bonta
,
Daniel Severus Dezmirean
Molecular Insights into Royal Jelly Anti-Inflammatory Properties and Related Diseases.
Life (Basel, Switzerland)
13 (7) (2023)
Sara Botezan
,
Gabriela-Maria Baci
,
Lilla Bagameri
,
Claudia Paşca
,
Daniel Severus Dezmirean
Current Status of the Bioactive Properties of Royal Jelly: A Comprehensive Review with a Focus on Its Anticancer, Anti-Inflammatory, and Antioxidant Effects.
Molecules (Basel, Switzerland)
28 (3) (2023)
Sara Botezan
,
Gabriela-Maria Baci
,
Lilla Bagameri
,
Claudia Paşca
,
Daniel Severus Dezmirean
Current Status of the Bioactive Properties of Royal Jelly: A Comprehensive Review with a Focus on Its Anticancer, Anti-Inflammatory, and Antioxidant Effects.
Molecules (Basel, Switzerland)
28 (3) (2023)
Sara Botezan
,
Gabriela-Maria Baci
,
Lilla Bagameri
,
Claudia Paşca
,
Daniel Severus Dezmirean
Current Status of the Bioactive Properties of Royal Jelly: A Comprehensive Review with a Focus on Its Anticancer, Anti-Inflammatory, and Antioxidant Effects.
Molecules (Basel, Switzerland)
28 (3) (2023)
Lilla Bagameri
,
Gabriela-Maria Baci
,
Daniel Severus Dezmirean
Royal Jelly as a Nutraceutical Natural Product with a Focus on Its Antibacterial Activity.
Pharmaceutics
14 (6) (2022)